CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-12 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +384,120 | 384,120 | ||
| 2017-07-03 | MOTT DAVID M Director | Grant or award · Option to purchase Ordinary Shares | +302,561 | 302,561 | ||
| 2017-07-03 | Behbahani Ali Director | Grant or award · Option to purchase Ordinary Shares | +220,788 | 220,788 | ||
| 2017-07-03 | Duncan Barbara Gayle Director | Grant or award · Option to purchase Ordinary Shares | +228,765 | 228,765 | ||
| 2017-07-03 | Zaks Tal Zvi Director | Grant or award · Option to purchase Ordinary Shares | +144,000 | 144,000 | ||
| 2017-07-03 | Thompson Peter A. Director | Grant or award · Option to purchase Ordinary Shares | +223,779 | 223,779 | ||
| 2017-07-03 | Sigal Charles Elliott Director | Grant or award · Option to purchase Ordinary Shares | +220,788 | 220,788 | ||
| 2017-07-03 | Kerr Giles Francis Bertram Director | Grant or award · Option to purchase Ordinary Shares | +144,000 | 144,000 | ||
| 2017-07-03 | Alleva Lawrence M Director | Grant or award · Option to purchase Ordinary Shares | +243,724 | 243,724 | ||
| 2017-03-27 | Viswanathan Ravi 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | Sonsini Peter W. 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | SANDELL SCOTT D 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | MOTT DAVID M Director | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | KERINS PATRICK J 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | Florence Anthony A. Jr. 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | BASKETT FOREST 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | BARRIS PETER J 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | BARRETT M JAMES 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | New Enterprise Associates 14, L.P. 10% owner | Purchase | +12,870,000 | $0.70 | $9.0M | 72,139,000 |
| 2017-03-27 | Thompson Peter A. Director | Purchase | +1,190,476 | $4.20 | $5.0M | 6,149,377 |
Page 22 of 23 · 454 trades